#120, Predicting Trial Success Before Recruitment with Orr Inbar from QuantHealth

AWS Health Innovation Podcast

Content provided by AWS Startups. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AWS Startups or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

20d ago 39:28

MP3•Episode home

What if you could peer into the future of a clinical trial before enrolling a single patient? In this episode of the AWS Health Innovation Podcast, Alex Merwin, Head of Growth for Healthcare & Life Science Startups at AWS, sits down with Orr Inbar, Co-Founder & CEO of QuantHealth, to explore their groundbreaking platform that's revolutionizing drug development through clinical trial simulation. Their technology is transforming how pharmaceutical companies evaluate and advance potential therapies.

1. How is QuantHealth reshaping pharmaceutical research?

By leveraging an extensive database of 350 million patient records and sophisticated AI models, QuantHealth's platform achieves an impressive 86% accuracy in predicting trial outcomes. This capability directly addresses the industry's persistent challenges of rising costs and high failure rates.

2. What fundamental industry challenges does QuantHealth address?

The pharmaceutical industry struggles with average development costs of $3 billion and timelines exceeding a decade. Modern precision medicine requirements have added new layers of complexity to the drug development process, making traditional approaches increasingly challenging.

3. How did QuantHealth evolve during the pandemic era?

Born during COVID-19, QuantHealth developed an AI-driven solution that effectively bridges the critical gap between preclinical and clinical stages. Their platform now processes thousands of trials annually, demonstrating remarkable precision in predicting outcomes.

4. What makes QuantHealth's technical approach unique?

The platform combines biological knowledge graphs with deep learning models to create digital twins of both drugs and patients. This innovative approach spans more than 50 medical indications and multiple treatment modalities, enabling comprehensive trial simulation.

5. What real-world impact has QuantHealth demonstrated?

Through partnerships with major pharmaceutical companies, QuantHealth has helped increase trial success rates by 15% while simultaneously reducing development timelines. Their simulation technology has made previously unfeasible trials possible.

Learn more about QuantHealth's innovative approach to clinical trial optimization at quanthealth.ai

Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.

Please take a moment and let us know what you think of the podcast, access our feedback survey here.

128 episodes

#Tech #Joe Shonkwiler